Please login or register first to view this content.
Urological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Sodium Bicarbonate May Mitigate Calcium Phosphate Stone Risk in CKD
Trodelvy Gets Accelerated Approval for Urothelial Cancer
Gemtesa Now Available for Overactive Bladder Treatment
FDA Clears Point-of-Care Test for Chlamydia, Gonorrhea
Vadadustat NDA Submitted for Anemia Due to Chronic Kidney Disease
Myrbetriq Approved for Pediatric Neurogenic Detrusor Overactivity
Hormone Therapy May Reduce Nocturia After Menopause
Kyzatrex Under Review for Primary and Secondary Male Hypogonadism
Tecentriq Indication for Prior-Platinum Treated Bladder Cancer Withdrawn
Jury Penalizes Physician for Failing to Follow Up on Abnormal Urinalysis
BPH Medications May Increase Heart Failure Risk
Terlipressin Bests Placebo in Type 1 Hepatorenal Syndrome
FDA to Review Difelikefalin for Chronic Kidney Disease-Associated Pruritus
Inappropriate Antibiotic Prescribing Common for Women With UTIs
Imfinzi Indication for Urothelial Carcinoma Withdrawn
Certain Prostate Drugs Tied to Risk for Parkinson Disease
Cabozantinib Prolongs PFS in Papillary Renal Cell Carcinoma
Adding Vibegron to BPH Meds Safe, Effective for Overactive Bladder
